Gene expression profiling of day 7 erythroblasts from RARS before and after treatment with G-CSF

Gene expression profiling of day 7 erythroblasts from RARS before and after treatment with G-CSF

Detalhes bibliográficos
Principais autores:	Nikpour, M, Pellagatti, A, Jadersten, M, Forsblom, A, Wainscoat, J, Boultwood, J, Hellstroem-Lindberg, E
Formato:	Conference item
Publicado em:	2007

Registros relacionados

Gene expression profiling of day 7 erythroblasts from refractory anemia with ringed sideroblasts (RARS) and microarray-based identification of erythroid granulocyte-CSF (G-CSF) targets
por: Nikpour, M, et al.
Publicado em: (2009)

Gene expression profiling of erythroblasts from refractory anaemia with ring sideroblasts (RARS) and effects of G-CSF.
por: Nikpour, M, et al.
Publicado em: (2010)

YI1 Gene expression profiling of day 7 erythroblasts from refractory anemia with ringed sideroblasts (RARS) and microarray-based identification of erythroid granulocyte-CSF (G-CSF) targets
por: Nikpour, M, et al.
Publicado em: (2009)

NEW INSIGHTS INTO THE BIOLOGY OF REFRACTORY ANEMIA WITH RING SIDEROBLASTS (RARS) AND IDENTIFICATION OF ERYTHROID G-CSF TARGETS BY GENE EXPRESSION PROFILING
por: Nikpour, M, et al.
Publicado em: (2009)

Lenalidomide selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5q deletion.
por: Jadersten, M, et al.
Publicado em: (2005)

Differential expression of genes related to JAK-STAT pathway activation or megakaryocyte differentiation/maturation in CD34+cells from patients with refractory anemia with ringed sideroblasts and thrombocytosis (RARS-T)
por: Malcovati, L, et al.
Publicado em: (2007)

Effects of L-leucine in 5q-syndrome and other RPS14-deficient erythroblasts
por: Yip, B, et al.
Publicado em: (2012)

Effects of L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts.
por: Yip, B, et al.
Publicado em: (2012)

Activation of the mTOR signaling pathway by L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts.
por: Yip, B, et al.
Publicado em: (2013)

Activation of the mTOR signaling pathway by L-leucine in 5q-syndrome and other RPS14-deficient erythroblasts
por: Yip, B, et al.
Publicado em: (2013)

The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts
por: Boultwood, J, et al.
Publicado em: (2008)

Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients.
por: Pellagatti, A, et al.
Publicado em: (2007)

Lenalidomide up-regulates SPARC and inhibits in vitro growth of the malignant clone in myelodysplastic syndrome patients with 5q deletion.
por: Pellagatti, A, et al.
Publicado em: (2006)

Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression.
por: Jädersten, M, et al.
Publicado em: (2009)

Gene Expression Profiling of CD34(+) Cells in Patients with Myelodysplastic Syndromes
por: Pellagatti, A, et al.
Publicado em: (2008)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 in the Myelodysplastic Syndromes and in Acute Myeloid Leukaemia
por: Boultwood, J, et al.
Publicado em: (2009)

L-leucine increases translation of RPS14 and LARP1 in erythroblasts from del(5q) myelodysplastic syndrome patients
por: Bello, E, et al.
Publicado em: (2018)

GM-CSF impairs erythropoiesis by disrupting erythroblastic island formation via macrophages
por: Weijie Cao, et al.
Publicado em: (2022-01-01)

Haploinsufficiency of ribosomal proteins and p53 activation in anemia: Diamond-Blackfan anemia and the 5q- syndrome.
por: Boultwood, J, et al.
Publicado em: (2012)

5q- syndrome.
por: Boultwood, J, et al.
Publicado em: (2012)

Del(5q) Myelodysplastic Stem Cells Exhibit Their Clonal Advantage Via Increased Adhesion to the Microenvironment
por: Scharenberg, C, et al.
Publicado em: (2011)

Bacterial Lipopolysaccharides Suppress Erythroblastic Islands and Erythropoiesis in the Bone Marrow in an Extrinsic and G- CSF-, IL-1-, and TNF-Independent Manner
por: Kavita Bisht, et al.
Publicado em: (2020-10-01)

The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts.
por: Jacqueline Boultwood, et al.
Publicado em: (2008-04-01)

Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression
por: Martin Jädersten, et al.
Publicado em: (2009-12-01)

Aberrant Expression of DOCK4 Leads to Disruption of the F-Actin Skeleton and Altered Membrane Stability in MDS Erythroblasts and Mature Erythrocytes
por: Sundaravel, S, et al.
Publicado em: (2012)

Aberrant Expression of DOCK4 Leads to Disruption of the F-Actin Skeleton and Altered Membrane Stability in MDS Erythroblasts and Mature Erythrocytes
por: Sundaravel, S, et al.
Publicado em: (2012)

Garland of Erythroblasts around a Macrophage: Erythroblastic Island
por: Chandan Kumar, et al.
Publicado em: (2020-05-01)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
por: Pellagatti, A, et al.
Publicado em: (2010)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
por: Pellagatti, A, et al.
Publicado em: (2010)

Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
por: Pellagatti, A, et al.
Publicado em: (2009)

YOLOv7-RAR for Urban Vehicle Detection
por: Yuan Zhang, et al.
Publicado em: (2023-02-01)

Erythroblast Enucleation
por: Ganesan Keerthivasan, et al.
Publicado em: (2011-01-01)

Erythroblast enucleation
por: Anna Rita Migliaccio
Publicado em: (2010-12-01)

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes (British Journal of Haematology (2008) 142, (57-64))
por: Pellagatti, A, et al.
Publicado em: (2009)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome.
por: Pellagatti, A, et al.
Publicado em: (2011)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
por: Pellagatti, A, et al.
Publicado em: (2010)

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes.
por: Pellagatti, A, et al.
Publicado em: (2008)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome
por: Pellagatti, A, et al.
Publicado em: (2011)

Gene expression profiling in the myelodysplastic syndromes.
por: Pellagatti, A, et al.
Publicado em: (2005)

L-leucine increases translation of RPS14 and LARP1 in erythroblasts from del(5q) myelodysplastic syndrome patients
por: Erica Bello, et al.
Publicado em: (2018-11-01)